Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination

This publication has 27 references indexed in Scilit:

• Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma
  JNCI Journal of the National Cancer Institute, 2004
• Docetaxel and hyperthermia: Factors that modify thermal enhancement
  Journal of Surgical Oncology, 2004
• Cancer Statistics, 2004
  CA: A Cancer Journal for Clinicians, 2004
• Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum
  Gynecologic Oncology, 2003
• Phase III Trial of Paclitaxel at Two Dose Levels, the Higher Dose Accompanied by Filgrastim at Two Dose Levels in Platinum-Pretreated Epithelial Ovarian Cancer: An Intergroup Study
  Journal of Clinical Oncology, 2003
• Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer
  Anti-Cancer Drugs, 2003
• Treatment of Relapsed Carcinoma of the Ovary with Single-Agent Paclitaxel Following Exposure to Paclitaxel and Platinum Employed as Initial Therapy
  Gynecologic Oncology, 2000
• Intraperitoneal chemotherapy in ovarian cancer
  Cancer Treatment Reviews, 2000
• Short communication: Thermosensitive liposomal taxol formulation: heatmediated targeted drug delivery in murine melanoma
  Melanoma Research, 1998
• Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
  New England Journal of Medicine, 1996